newsfilter
← Latest News
GlobeNewswire·

Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market

WALTHAM, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it has entered into a